AWS
AST

Aris Wealth Services’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

Aris Wealth Services’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$0 Hold
13
– – ﹤0.01% 537
2015
Q2 		$0 Hold
13
– – ﹤0.01% 568
2015
Q1 		$0 Buy
+13
New +$64 ﹤0.01% 586

Other funds holding AST

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Aris Wealth Services's AST Position: Q3 2015 in Review

Aris Wealth Services held its Asterias Biotherapeutics Inc. Series A (AST) position steady in Q3 2015 at 13 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Aris Wealth Services first reported a position in AST in Q1 2015 and has held it in 3 quarters since. 58 funds tracked by Wall St. Rank hold AST as of Q3 2015.

  • Aris Wealth Services held 13 shares of Asterias Biotherapeutics Inc. Series A worth $0 as of Q3 2015.
  • Aris Wealth Services left its Asterias Biotherapeutics Inc. Series A share count unchanged in Q3 2015.
  • Asterias Biotherapeutics Inc. Series A made up ﹤0.01% of Aris Wealth Services's portfolio in Q3 2015, its #537 holding.
  • Aris Wealth Services first reported a position in Asterias Biotherapeutics Inc. Series A in Q1 2015 and has held it in 3 quarters since.
  • 58 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q3 2015.

Based on Aris Wealth Services's 13F filing for Q3 2015, filed 10 Nov 2015.